CClinicalTrials.gg
CompletedNCT01282931Updated Oct 12, 2011

Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer

An observational study in Metastatic Breast Cancer, sponsored by Health Outcomes Solutions. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-10-12.

Sponsored by Health Outcomes Solutions · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of the study is to understand the meaning of progression-free survival for women with metastatic breast cancer and to use this understanding to create and distribute a new questionnaire to assess the effect progression has on a woman's functioning and well-being.

Read the detailed description

This study is being conducted in three stages. Stages I and II are complete. Participation in Stage III requires the completion of an online survey. The survey may be accessed at the following link:

https://www.surveymonkey.com/s/mbc3survey

Compensation options for eligible participants are listed at the end of the survey.

Eligibility will be confirmed in follow-up call/email by study staff.

02

Conditions studied

  • Metastatic Breast Cancer

Browse trials for

Keywords

  • Women
  • Stage IV
  • Metastatic
  • Breast Cancer
  • Progressed
  • Progression
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 200 is close to the median of 184 across 2,642 observational studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Health Outcomes Solutions is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Female 18 and older U.S. resident Clinical diagnosis of metastatic breast cancer

Eligibility criteria

Inclusion Criteria:

  • Female
  • Age 18 and older
  • Clinical diagnosis of metastatic breast cancer
  • U.S. resident
  • Able to speak and read English
  • Willing to sign and informed consent
  • Willing to self-administer one online questionnaire that will take approximately 15 minutes to complete
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
06

Study locations

1 site
  • Health Outcomes Solutions
    Winter Park, Florida 32790, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 12, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01282931
Lead sponsor
Health Outcomes Solutions
Responsible party
Susan Mathias (Principal Investigator, Health Outcomes Solutions) — Principal investigator
First posted
Jan 25, 2011
Start date
Jan 2011
Primary completion
Mar 2011
Completion
Mar 2011
Last update
Oct 12, 2011

Study contacts

Susan D. Mathias
principal investigator · Health Outcomes Solutions

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion